|
ИСТИНА |
Войти в систему Регистрация |
ИСТИНА ИНХС РАН |
||
Potential of 1.3-diethylbenzimidazolium triiodide in experimental therapy for lung cancerстатья
Статья опубликована в высокорейтинговом журнале
Статья опубликована в журнале из списка Web of Science и/или Scopus- Авторы: Shikhlyarova Alla I., Trepitaki Lidia K., Kaplieva Irina V., Frantsiyants Elena M., Kharagezov Dmitry A., Milakin Anton G., Leyman Igor A., Stateshny Oleg N., Volkova Viktoriya L., Lazutin Yuriy N.
- Журнал: Journal of Clinical Oncology
- Номер: 39
- Год издания: 2021
- Издательство: American Society of Clinical Oncology
- Местоположение издательства: United States
- DOI: 10.1200/JCO.2021.39.15_suppl.e15094
- Аннотация: The practice of thoracic oncology demonstrates that the lungs often become affected by cancer. The antitumor effect of chemoradiation therapy can be poor, and surgical treatment is associated with reduced functionality of the organ and therefore reduced quality of life of patients. Therefore, nonspecific agents are required that combine a pronounced antitumor effect and, at the same time, restore pulmonary tissue. Our purpose was to study the effects of 1,3-diethylbenzimidazolium triiodide in a rat model of lung cancer by morphological analysis of pulmonary tissues.
- Добавил в систему: Харагезов Дмитрий Акимович